EPoSS - The Product Driven Platform

6th General Assembly & Annual Forum of the European Technology Platform on Nanomedicine

The event will take place in Barcelona on 19 to 21 October 2011.

  • General Assembly and Annual Conference
When 19 October 2011 09:00 AM to
21 October 2011 05:00 PM
Where Barcelona, Spain
Add event to calendar vCal

“Nanomedicine is certainly the most promising enabling technology to achieve breakthroughs in medical technologies. Nanomedicine will strongly contribute to driving the future of medicine. A first step to kick off necessary actions will be done in October in Barcelona.” says Bertrand Loubaton, Director at GE Healthcare and chairman of the European Technology Platform ETPN.


The forum is dedicated to the members of ETP Nanomedicine and to the European Nanomedicine Community at large and will essentially focus this year on discussing strategic opportunities for the Nanomedicine stakeholders coming from industry, academia, clinics and the public sector. The European Commission (DG Research & Innovation) will also be present to discuss the development of the future European Nanomedicine policy activities and initiatives.

Furthermore, a key target of this forum will be to raise awareness for translational research, clinical needs and necessary conditions to make Nanomedicine happen in Europe. In particular, this year’s event will focus on the identification of industrial opportunities and needs, on the strategies for adapting regulations, funding schemes and infrastructures, on clinical challenges and on translational strategies of Nanomedicine.

Further information, such as the programme, travel details as well as the online registration form, are available on the ETP Nanomedicine website at: www.etp-nanomedicine.eu/forum-2011.

About the ETPN

The European Technology Platform on Nanomedicine is an industry driven initiative set up together with the European Commission. The platform fosters the application of nanotechnology to achieve medical breakthroughs. Nanomedicine makes use of the often very different physical, chemical and biological properties at the nanometer scale to influence biological processes in novel ways. Therefore, Nanomedicine can potentially enable the early detection and prevention of diseases and essentially improve their diagnosis, treatment and healing.

In summer 2011 the ETP Nanomedicine published a white paper addressing the issue of “Translation in Nanomedicine” as well as giving recommendations to further advance Nanomedicine research in Europe. The intention of the paper is to underpin the importance of Nanomedicine for Europe and the need for public and private funding, also in regard to the new Framework Programme of the EC titled “Horizon 2020”.


More information about this event…

Document Actions

  • EPoSS © 2005 – 2018